Company intelligence / Profile preview

Schorr Biologics Consulting

Boston, Massachusetts, USpmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Development stage: Other

Overview

There is no evidence that "Schorr Biologics Consulting" develops its own therapeutics. The similarly named firm provides strategic planning and tactical support for process development and manufacturing of biologic products, including recombinant proteins and live biotherapeutic products. Services include evaluation/selection of CMOs/CROs, regulatory document authoring, and oversight of manufacturing processes for clients in the biotech sector.

Modalities: Recombinant proteinLive biotherapeutic product therapy
Industry: Consulting

Beyond the preview

Go deeper on Schorr Biologics Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Schorr Biologics Consulting.

Explore the full profile